Scienture Holdings, Inc. (SCNX)vsWellgistics Health, Inc. Common Stock (WGRX)
SCNX
Scienture Holdings, Inc.
$0.36
-5.26%
HEALTHCARE · Cap: $14.33M
WGRX
Wellgistics Health, Inc. Common Stock
$4.35
+1.40%
HEALTHCARE · Cap: $9.35M
Smart Verdict
WallStSmart Research — data-driven comparison
Wellgistics Health, Inc. Common Stock generates 2838% more annual revenue ($14.03M vs $477,680). WGRX leads profitability with a 0.0% profit margin vs 0.0%. SCNX earns a higher WallStSmart Score of 33/100 (F).
SCNX
Avoid33
out of 100
Grade: F
WGRX
Avoid30
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+21.4%
Fair Value
$0.57
Current Price
$0.36
$0.21 discount
Intrinsic value data unavailable for WGRX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 449.1% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -0.1% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : SCNX
The strongest argument for SCNX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 449.1% demonstrates continued momentum.
Bull Case : WGRX
The strongest argument for WGRX centers on Debt/Equity.
Bear Case : SCNX
The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.
Bear Case : WGRX
The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
SCNX profiles as a hypergrowth stock while WGRX is a value play — different risk/reward profiles.
SCNX is growing revenue faster at 449.1% — sustainability is the question.
SCNX generates stronger free cash flow (-3M), providing more financial flexibility.
Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SCNX scores higher overall (33/100 vs 30/100) and 449.1% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Scienture Holdings, Inc.
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Scienture Holdings, Inc. (SCNX) is a biotechnology firm focused on developing advanced therapeutic solutions for neurological disorders, utilizing an innovative drug development pipeline backed by a skilled research team. With a strong emphasis on addressing unmet medical needs, Scienture is poised to enhance patient outcomes while navigating the complexities of regulatory pathways. The company’s dedication to scientific rigor and its strategic partnerships not only bolster its growth potential but also position SCNX as a significant contributor to advancements in global healthcare. As the demand for effective neurological treatments grows, Scienture aims to leverage emerging opportunities within the expanding healthcare landscape.
Wellgistics Health, Inc. Common Stock
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.
Compare with Other PHARMACEUTICAL RETAILERS Stocks
Want to dig deeper into these stocks?